| 注册
首页|期刊导航|中国医学创新|血塞通联合氟桂利嗪治疗偏头痛的临床疗效观察

血塞通联合氟桂利嗪治疗偏头痛的临床疗效观察

朱崇惠 陈坤 马敏麟

中国医学创新Issue(31):112-113,2.
中国医学创新Issue(31):112-113,2.DOI:10.3969/j.issn.1674-4985.2013.31.051

血塞通联合氟桂利嗪治疗偏头痛的临床疗效观察

Observation the Clinical Effect of Xuesetong Capsule Combined with Sibelium for Treatment of Migraine

朱崇惠 1陈坤 1马敏麟1

作者信息

  • 1. 云南省昭通市第一人民医院 云南 昭通 657000
  • 折叠

摘要

Abstract

Objective:To observe the clinical effect of Xuesetong capsule combined with sibelium for treatment of migraine. Method:90 patients with migraine in our hospital from April 2011 to February 2013 were randomly divided into observation group(n=45)and control group(n=45). Observation group was given Xuesetong capsule combined with sibelium,and control group was given sibelium. Analyzed the effects of two groups. Result:After treatment,the total effective rate was 93.33%,VAS grade was(3.13±1.12)score,time of seizure duration was(3.37±0.49)h,seizure frequency was(8.02±0.96)times/month in the observation group;The control group were 75.56%,(5.24±1.53)score,(6.34±0.58)h,(14.24±0.88)times/month. The indicators of observation group were better than the control group,the difference statistically significant(P<0.05). Conclusions:The clinical effect of Xuesetong capsule combined with sibelium for treatment of migraine is exact,which has strengthening effect. It is worthy to be popularized.

关键词

血塞通/氟桂利嗪/偏头痛

Key words

Xuesetong capsule/Sibelium/Migraine

引用本文复制引用

朱崇惠,陈坤,马敏麟..血塞通联合氟桂利嗪治疗偏头痛的临床疗效观察[J].中国医学创新,2013,(31):112-113,2.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文